- Home
- UDR vs MRNA Comparison
UDR vs MRNA Comparison
Compare UDR & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UDR
- MRNA
- Stock Information
- Founded
- UDR 1972
- MRNA 2010
- Country
- UDR United States
- MRNA United States
- Employees
- UDR N/A
- MRNA N/A
- Industry
- UDR Real Estate Investment Trusts
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UDR Real Estate
- MRNA Health Care
- Exchange
- UDR Nasdaq
- MRNA Nasdaq
- Market Cap
- UDR 13.7B
- MRNA 13.4B
- IPO Year
- UDR N/A
- MRNA 2018
- Fundamental
- Price
- UDR $38.68
- MRNA $27.61
- Analyst Decision
- UDR Hold
- MRNA Hold
- Analyst Count
- UDR 13
- MRNA 20
- Target Price
- UDR $45.92
- MRNA $46.76
- AVG Volume (30 Days)
- UDR 2.2M
- MRNA 9.0M
- Earning Date
- UDR 07-30-2025
- MRNA 08-01-2025
- Dividend Yield
- UDR 4.38%
- MRNA N/A
- EPS Growth
- UDR N/A
- MRNA N/A
- EPS
- UDR 0.39
- MRNA N/A
- Revenue
- UDR $1,714,882,000.00
- MRNA $3,078,000,000.00
- Revenue This Year
- UDR $0.99
- MRNA N/A
- Revenue Next Year
- UDR $3.49
- MRNA $10.04
- P/E Ratio
- UDR $102.04
- MRNA N/A
- Revenue Growth
- UDR 2.38
- MRNA N/A
- 52 Week Low
- UDR $36.61
- MRNA $23.15
- 52 Week High
- UDR $47.55
- MRNA $102.90
- Technical
- Relative Strength Index (RSI)
- UDR 33.24
- MRNA 36.94
- Support Level
- UDR $39.86
- MRNA $33.35
- Resistance Level
- UDR $40.81
- MRNA $34.70
- Average True Range (ATR)
- UDR 0.84
- MRNA 1.47
- MACD
- UDR -0.16
- MRNA -0.66
- Stochastic Oscillator
- UDR 12.66
- MRNA 11.53
About UDR UDR Inc.
UDR Inc is a real estate investment trust that owns, operates, acquires, renovates, develops, redevelops, disposes of, and manages multifamily apartment communities in targeted markets located in the United States. The company has two reportable segments; Same-Store Communities segment represents those communities acquired, developed, and stabilized; and Non-Mature Communities/Other segment represents those communities that do not meet the criteria to be included in Same-Store Communities, including, but not limited to, recently acquired, developed and redeveloped communities, and the non-apartment components of mixed-use properties. It generates key revenue from Same-Store Communities.
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.